2-O-(2-Methoxyethyl)-D-ribose | 257862-48-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-O-(2-Methoxyethyl)-D-ribose
• 英文别名: (2R,3R,4R)-3,4,5-trihydroxy-2-(2-methoxyethoxy)pentanal
• CAS: 257862-48-9
• 化学式: C₈H₁₆O₆
• 分子量: 208.21
• InChiKey: WYGGONZRIKQSRE-GJMOJQLCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.4
• 重原子数：
  14
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  96.2
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• [EN] NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF<br/>[FR] COMPOSITIONS D'ACIDE NUCLÉIQUE-POLYPEPTIDE ET UTILISATIONS DE CELLES-CI
  申请人：AVIDITY BIOSCIENCES INC

  公开号：WO2020247782A1

  公开（公告）日：2020-12-10

  Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.

  本文披露了包括与修饰的多核苷酸分子和聚合物结合的结合基团的组合物和药物配方。本文还描述了利用包括结合基团与多核苷酸分子和聚合物结合的组合物或药物配方治疗癌症的方法。
• CATIONIC LIPID
  申请人：Takeda Pharmaceutical Company Limited

  公开号：US20170197903A1

  公开（公告）日：2017-07-13

  The present invention provides a technology which enables introduction of an active ingredient (e.g. nucleic acids) into various cells with a high efficiency, and compounds used therefor. The present invention provides a compound represented by the formula: [wherein, each symbol is as defined in the present description] or a salt thereof.

  本发明提供了一种技术，可以高效地将活性成分（例如核酸）引入各种细胞中，以及用于该技术的化合物。本发明提供了一种由以下公式表示的化合物：[其中，每个符号如本说明书中所定义]或其盐。
• [EN] UNA AMIDITES AND USES THEREOF<br/>[FR] AMIDITES D'UNA ET LEURS UTILISATIONS
  申请人：AVIDITY BIOSCIENCES INC

  公开号：WO2020247818A1

  公开（公告）日：2020-12-10

  Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a modified polynucleic acid molecule and a polymer. Also described herein include methods for treating a disease which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.

  本文披露了包含结合基团与修饰的多核苷酸分子和聚合物结合的组合物和药物配方。本文还描述了利用包含结合基团与多核苷酸分子和聚合物结合的组合物或药物配方进行治疗疾病的方法。
• CATIONIC LIPIDS
  申请人：Takeda Pharmaceutical Company Limited

  公开号：US20200331841A1

  公开（公告）日：2020-10-22

  The present invention provides a technique that enables introduction of active ingredients, in particular, nucleic acids, into cells with superior efficiency; and cationic lipids, etc., for use in the technique. The compound or a salt thereof according to the present invention is a compound represented by formula (I) or a salt thereof. In formula (I), n represents an integer of 2 to 5, R represents a linear C 1-5 alkyl group, a linear C 7-11 alkenyl group, or a linear C 11 alkadienyl group, and wavy lines each independently represent a cis-bond or a trans-bond.

  本发明提供了一种技术，能够以优越的效率将活性成分，特别是核酸，引入细胞中；以及用于该技术的阳离子脂质等。根据本发明的化合物或其盐是由式（I）表示的化合物或其盐。在式（I）中，n代表2到5的整数，R代表线性C1-5烷基基团、线性C7-11烯基基团或线性C11烯二烯基团，波浪线各自独立表示顺式键或反式键。
• Antisense oligonucleotide modulation of STAT3 expression
  申请人：Karras G. James

  公开号：US20050074879A1

  公开（公告）日：2005-04-07

  Compounds, compositions and methods are provided for inhibiting the expression of human STAT3. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding STAT3. Methods of using these oligonucleotides for inhibition of STAT3 expression and for promotion of apoptosis are provided. Methods for treatment of diseases, particularly inflammatory diseases and cancers, associated with overexpression or constitutive activation of STAT3 or insufficient apoptosis are also provided.

  提供了用于抑制人STAT3表达的化合物、组合物和方法。这些组合物包括针对编码STAT3的核酸的反义寡核苷酸。提供了使用这些寡核苷酸抑制STAT3表达和促进凋亡的方法。还提供了用于治疗与STAT3过度表达或常规激活或凋亡不足有关的疾病，特别是炎症性疾病和癌症的方法。